Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung- The Knockout Punch

被引:12
|
作者
Tjong, M. C. [1 ]
Louie, A., V [1 ]
Singh, A. K. [2 ]
Videtic, G. [3 ]
Stephans, K. [3 ]
Plumridge, N. [4 ]
Harden, S. [4 ]
Slotman, B. J. [5 ]
Alongi, F. [6 ,7 ]
Guckenberger, M. [8 ]
Siva, S. [4 ]
机构
[1] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[2] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Amsterdam Univ Med Ctr VUMC, Amsterdam, Netherlands
[6] IRCCS Sacro Cuore Don Calabria Hosp, Adv Radiat Oncol Dept, Negrar Verona, Italy
[7] Univ Brescia, Brescia, Italy
[8] Univ Zurich, Univ Hosp Zurich, Zurich, Switzerland
关键词
Ablative; lung; metastasis; NSCLC; radiotherapy; stereotactic; MEDICALLY INOPERABLE PATIENTS; RADIATION-THERAPY; CANCER; OLIGOMETASTASES; OUTCOMES; PHASE-2; TUMORS; SBRT; METASTASES; MANAGEMENT;
D O I
10.1016/j.clon.2022.02.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This overview summarises the current evidence on efficacy and safety of single-fraction stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung metastases, in comparison with the more widely adapted multi-fraction SABR regimens. A literature search using the Medline database through PubMed was carried out using the following key words: ('stereotactic' or 'sabr' or 'sbrt'), ('radiotherapy' or 'radiation therapy'), ('lung' or 'thorax' or 'thoracic' or 'chest'), ('cancer' or 'metasta-' or 'oligometasta-'), alongside: (i) ('single-fraction' or 'single-dose') to identify trials and cohort studies with single-fraction SABR to lung malignant tumours and (ii) ('fraction' or 'schedule') limiting the search to 'clinical trial' and 'randomized controlled trial' to ensure thorough capture of lung SABR trials comparing different fractionations. The review discusses the radiobiological, technical and organ at risk considerations of single-fraction SABR to the lung. (C) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E183 / E194
页数:12
相关论文
共 50 条
  • [1] Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung
    Kang, Therese MJ.
    Hardcastle, Nicholas
    Singh, Anurag K.
    Slotman, Ben J.
    Videtic, Gregory M. M.
    Stephans, Kevin L.
    Counago, Felipe Coun
    V. Louie, Alexander
    Guckenberger, Matthias
    V. Harden, Susan
    Plumridge, Nikki M.
    Siva, Shankar
    [J]. LUNG CANCER, 2022, 170 : 185 - 193
  • [2] Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers
    Greenwood, H.
    Hassan, J.
    Fife, K.
    Ajithkumar, T. V.
    Jayaprakash, K. Thippu
    [J]. CLINICAL ONCOLOGY, 2023, 35 (12) : 773 - 786
  • [3] Duodenal Toxicity in Single-fraction Stereotactic Body Radiotherapy
    Murphy, J. D.
    Dieterich, S.
    Chang, D. T.
    Koong, A. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S29 - S30
  • [4] Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?
    Fernandez, Castalia
    Navarro-Martin, Arturo
    Bobo, Andrea
    Cabrera-Rodriguez, Joaquin
    Calvo, Patricia
    Chicas-Sett, Rodolfo
    Luna, Javier
    de Dios, Nuria Rodriguez
    Counago, Felipe
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (02): : 101 - 115
  • [5] Single-fraction stereotactic ablative body radiotherapy for sternal metastases in oligometastatic breast cancer: Technique and single institution experience
    Li, Michelle P.
    Kelly, Dianne
    Tan, Jennifer
    Siva, Shankar
    Kron, Tomas
    David, Steven
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (04) : 580 - 585
  • [6] Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases
    Filippi, Andrea R.
    Badellino, Serena
    Guarneri, Alessia
    Levis, Mario
    Botticella, Angela
    Mantovani, Cristina
    Ragona, Riccardo
    Racca, Patrizia
    Buffoni, Lucio
    Novello, Silvia
    Ricardi, Umberto
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2014, 13 (01) : 37 - 45
  • [7] Single-fraction stereotactic body radiotherapy for nodal oligorecurrent prostate cancer
    Loi, M.
    Simontacchi, G.
    Detti, B.
    Di Cataldo, V.
    Bonomo, P.
    Masi, L.
    Doro, R.
    Bonucci, I.
    Cipressi, S.
    Desideri, I.
    Greto, D.
    Becherini, C.
    Delli Paoli, C.
    Grassi, R.
    Lo Russo, M.
    Meattini, I.
    Scoccianti, S.
    Mangoni, M.
    Livi, L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S724 - S725
  • [8] Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy
    Finazzi, Tobias
    de Koste, John R. van Sornsen
    Palacios, Miguel A.
    Spoelstra, Femke O. B.
    Slotman, Berend J.
    Haasbeek, Cornelis J. A.
    Senan, Suresh
    [J]. PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2020, 14 : 17 - 23
  • [9] A strategy to reduce fraction number in peripheral lung stereotactic ablative body radiotherapy
    O'Keeffe, Serena
    Higgins, Martin J.
    Fleming, Cathy
    Armstrong, John
    Thirion, Pierre
    McClean, Brendan
    Vintro, Luis Leon
    [J]. PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 26
  • [10] Implementation of Single-Fraction Lung Stereotactic Ablative Radiotherapy in a Multicenter Provincial Cancer Program During the COVID-19 Pandemic
    Mou, Benjamin
    Hyde, Derek
    Araujo, Cynthia
    Bartha, Leigh
    Bergman, Alanah
    Liu, Mitchell
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)